Company Overview and News

 
CIRCOR Aerospace & Defense California Receives AS9100 Rev D Certification

2018-04-10 globenewswire
CORONA, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- CIRCOR Aerospace Inc., a CIRCOR International company, announced that its Aerospace & Defense California business has been awarded ISO 9001:2015 + AS9100 D certification by its registration partner, SAI Global.
Upvote Downvote

 
Snow crab fishery's 'sustainable' label suspended in wake of whale deaths

2018-03-20 cbc.ca
Canada's lucrative snow crab fishery in the southern Gulf of St. Lawrence has had its certification as an environmentally sustainable fishery suspended.
Upvote Downvote

 
Snow crab fishery's sustainability designation suspended in wake of whale deaths

2018-03-20 cbc.ca
Canada's lucrative Gulf of St. Lawrence snow crab fishery has had its certification as an environmentally sustainable fishery suspended.
Upvote Downvote

 
Celebrate Ethics & Compliance Professionals on Compliance Officer Day (26 September)

2017-09-26 prnewswire
SYDNEY, Sept. 15, 2017 /PRNewswire/ -- Compliance Officer Day, observed on 26 September each year, is a global event to recognise the important work of professionals who have dedicated their careers to the field of ethics and compliance. 
Upvote Downvote

 
Snow crab fishery to keep 'sustainable' label amid endangered whale deaths

2017-09-22 cbc.ca
After an unprecedented number of deaths this summer, CBC News is bringing you an in-depth look at the endangered North Atlantic right whale. This week, in a series called Deep Trouble, CBC explores the perils facing right whales.
Upvote Downvote

 
Celebrate Ethics & Compliance Professionals on Compliance Officer Day (26 September)

2017-09-15 prnewswire
SYDNEY, Sept. 15, 2017 /PRNewswire/ -- Compliance Officer Day, observed on 26 September each year, is a global event to recognise the important work of professionals who have dedicated their careers to the field of ethics and compliance. 
Upvote Downvote

 
Global Market for Chemical Testing Services to Reach a Valuation of US$ 34,025 Mn by 2025 end

2017-08-10 prnewswire
A new report by Future Market Insights titled "Chemical Testing Services Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2025" throws light on the performance of the global chemical testing services market over an eight year forecast period and provides insights on the various factors impacting the global market over the said period.
Upvote Downvote

 
SAI Global's Environmental Health and Safety Risk Management Software now named a 'Leader' from 'Innovator'

2017-07-26 prnewswire
SYDNEY, July 26, 2017 /PRNewswire/ -- SAI Global, a leading provider of integrated risk management solutions, announced their environmental, health and safety (EHS) risk management software, Cintellate, has achieved an EHS Leader ranking by Verdantix in their 2017 Green Quadrant; an upward move from 2016 when the software was recognised in the Innovator quadrant.
Upvote Downvote

 
SAI Global kündigt Peter Granat als neuen Chief Executive Officer an

2017-07-15 prnewswire
LONDON, 15. Juli 2017 /PRNewswire/ -- SAI Global, ein führender Anbieter integrierter Risikomanagement-Lösungen und australischer Immobiliendienstleistungen, kündigte heute an, dass Peter Granat zum neuen Global Chief Executive Officer (CEO) des Unternehmens ernannt wurde.
Upvote Downvote

 
Peter Granat est le nouveau PDG de SAI Global

2017-07-15 prnewswire
LONDRES, 15 juillet 2017 /PRNewswire/ -- SAI Global, l'un des principaux prestataires de solutions de gestion intégrée des risques et de services immobiliers en Australie, a annoncé aujourd'hui que Peter Granat a été nommé PDG de Global.
Upvote Downvote

 
SAI Global benoemt Peter Granat als nieuwe Chief Executive Officer

2017-07-15 prnewswire
LONDEN, 15 juli 2017 /PRNewswire/ -- SAI Global, een toonaangevende leverancier van geïntegreerde oplossingen voor risicobeheer, en Australian Property Services kondigden vandaag aan dat Peter Granat benoemd is als de nieuwe wereldwijde Chief Executive Officer (CEO) van het bedrijf.
Upvote Downvote

 
SAI Global anuncia Peter Granat como novo diretor executivo

2017-07-14 prnewswire
LONDRES, 14 de julho de 2017 /PRNewswire/ -- A SAI Global, uma importante fornecedora de soluções para gerenciamento de risco integradas e serviços relacionados a propriedades australianas, anunciou hoje que Peter Granat foi designado como o novo diretor executivo global (CEO) da empresa.
Upvote Downvote

 
SAI Global announces Peter Granat as new Chief Executive Officer

2017-07-14 prnewswire
LONDON, July 13, 2017 /PRNewswire/ -- SAI Global, a leading provider of integrated risk management solutions, and Australian property services, announced today that Peter Granat has been appointed the company's new Global Chief Executive Officer (CEO).
Upvote Downvote

 
Finance news you need to know today

2017-07-02 perthnow.com.au
THE Australian market looks set to open higher after two of Wall Street’s indexes rose despite the negative trend of global markets. At 0700 AEST on Monday, the share price futures index was up 21 points, or 0.37 per cent, at 5,670.
Upvote Downvote

 
BRC Global Standards Held 2nd Annual Food Safety Awards in Florida

2017-04-28 prnewswire
The BRC Global Standards Food Safety (Americas) Awards Program was held on 4th-5th April 2017 in Florida, USA. The event felicitated individuals and organizations who are committed to developing the BRC Global Standards certification scheme and the wider food safety industry in the Americas markets.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...